NCT02269306 is a NA clinical trial of clomiphen citrate in Anovulation, sponsored by Menoufia Obstetrics and Gynecology Group.

Who is sponsoring NCT02269306?

NCT02269306 is sponsored by Menoufia Obstetrics and Gynecology Group.

What drugs are being tested in NCT02269306?

Interventions in NCT02269306: clomiphen citrate.

What condition does NCT02269306 study?

NCT02269306 studies Anovulation.

Is NCT02269306 still recruiting?

NCT02269306 is currently completed. Last updated 16 October 2014.

Last reviewed 2014-10-16 · How we verify

NCT02269306

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Visceral Fat Area and Other Predictors of Ovarian Response During Clomiphene Citrate Ovulation Induction in Patients With Polycystic Ovary Syndrome

Completed NA Last updated 16 October 2014

What this trial tests

NA trial testing clomiphen citrate in Anovulation in 150 participants. Completed in 1 January 2013.

Timeline

1 January 2011

Primary endpoint
1 January 2013

1 January 2013

Quick facts

Lead sponsor	Menoufia Obstetrics and Gynecology Group
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Enrollment	150
Start date	1 January 2011
Primary completion	1 January 2013
Estimated completion	1 January 2013
Sites	1 location across Egypt

Drugs / interventions tested

clomiphen citrate — full drug profile →

Conditions studied

Anovulation — all drugs for Anovulation →

Sponsor

Menoufia Obstetrics and Gynecology Group — full company profile →

Who can join

Adults 18 to 40, female only, with Anovulation. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

ovulation
Time frame: 3 months ( cycles)

Sponsor's own description

The purpose of this study is to determine whether Visceral fat area and other criteria assessed during initial screening could predict the response to ovulation induction with clomiphene citrate (CC) in patients with polycystic ovary syndrome (PCOS).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Predictors of patient responses to ovulation induction with clomiphene citrate in patients with polycystic ovary syndrome experiencing infertility.
Ellakwa HE, Sanad ZF, Hamza HA, Emara MA, et al · · 2016 · cited 20× · PMID 26848057 · DOI 10.1016/j.ijgo.2015.09.008

Verify or expand the search:

Other recruiting trials for Anovulation

Currently open trials in the same condition.

NCT07159880 — Letrozole Extended vs Traditional Therapy for Ovulation Induction in Women With PCOS (PROLEx-PCOS) · NA · recruiting
NCT04650880 — Effect of Vitamin D on Ovulation Rate in Women With Polycystic Ovary Syndrome · NA · recruiting

Other Menoufia Obstetrics and Gynecology Group trials

Trials by the same sponsor.

NCT04161521 — Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02269306 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Menoufia Obstetrics and Gynecology Group
Last refreshed: 16 October 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02269306.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing